Y10S 424/83
Involving temperature-sensitive mutant bacterium
Official title: involving temperature-sensitive mutant bacterium
Y10S424/83 (Involving temperature-sensitive mutant bacterium) appears on 6 US grants and 0 published applications in this corpus.
Search patents in Y10S- Granted patents
- 6
- Published applications
- 0
- Assignees
- 5
- Inventors
- 12
- Latest grant
- 12 Mar 1991
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Pasteurella multocida vaccine12 Mar 1991US 4,999,191 AUniversity of Georgia Research Foundation, Inc.
- Process for preparation of improved mutant strain of Bordetella bronchiseptica useful for live attenuated vaccine for protection of B. bronchiseptica infection and live attenuated AR vaccine produced therefrom13 Sep 1988US 4,770,875 AThe Kitasato Institute
- Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype21 Jul 1987US 4,681,762 AResearch Corporation
- Method of the preparation of improved mutant strain of Bordetella bronchiseptica useful as live attenuated vaccine for prophlaxis of B. bronchiseptica infection26 Jun 1984US 4,456,588 AJuridical Foundation The Chemo-Sero-Therapeutic Research Institute, Nippon Vaccine Co., Ltd.
- Turkey rhinotracheitis vaccine5 Apr 1983US 4,379,140 ABrigham Young University
No published applications in this class yet.
Most cited
By later US patents
- Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype21US 4,337,314 AResearch Corporation · 1982
- Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype17US 4,681,762 AResearch Corporation · 1987
- Pasteurella multocida vaccine12US 4,999,191 AUniversity of Georgia Research Foundation, Inc. · 1991
- Process for preparation of improved mutant strain of Bordetella bronchiseptica useful for live attenuated vaccine for protection of B. bronchiseptica infection and live attenuated AR vaccine produced therefrom6US 4,770,875 AThe Kitasato Institute · 1988
- Turkey rhinotracheitis vaccine5US 4,379,140 ABrigham Young University · 1983